[Use of fibrinolytic agents during surgical treatment for submacular hemorrhages of various etiology].
Sosnovskiĭ
V V
VV
Sdobnikova
S V
SV
D000818:Animals; D002415:Cats; D002986:Clinical Trials as Topic; D003627:Data Interpretation, Statistical; D004195:Disease Models, Animal; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008268:Macular Degeneration / Q000150:complications; D011817:Rabbits; D012166:Retinal Hemorrhage / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000601:surgery*; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome; D014792:Visual Acuity; D014821:Vitrectomy
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator